Prebiotics are not well digested in the
upper gut and are therefore available to be metabolised by commensal as well as
probiotically supplemented bacteria residing in the lower GI tract. Studies
suggest that such non‑digestible oligosaccharides may have a range of health
benefits.
A combination of probotics and prebiotics is
known as synbiotics which boost the number of beneficial bacteria and improve
the colonisaion in the gut.
The gut microbiota plays an essential role
in intestinal immunity. the treament with GOS lead to a significant increase in the percentage of NK cells in the spleen and a 1.5-fold increase in fecal Bifidobacterium ssp. These data suggest that GOS reduces colitis by modulating the function and trafficking of NK cells and may provide
a novel therapeutic strategy for individuals with inflammatory bowel disease.
No comments:
Post a Comment